Conjugated equine estrogens inhibit progression of atherosclerosis but have no effect on intimal hyperplasia or arterial remodeling induced by balloon catheter injury in monkeys

Journal of the American College of Cardiology

Volumn 31, Issue 5, 1998, Pages 1158-1164

  Geary, Randolph L ^a   Adams, Michael R ^a   Benjamin, Marshall E ^a   Williams, J Koudy ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONJUGATED ESTROGEN; ESTRADIOL; ESTRONE; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY INJURY; ARTERY INTIMA PROLIFERATION; ARTICLE; ATHEROSCLEROSIS; BALLOON CATHETER; CONTROLLED STUDY; FEMALE; ILIAC ARTERY; MONKEY; NONHUMAN; ORAL DRUG ADMINISTRATION; OVARIECTOMY; PRIORITY JOURNAL;

ANIMALS; ARTERIOSCLEROSIS; BALLOON DILATATION; CELL DIVISION; DISEASE PROGRESSION; ESTROGENS, CONJUGATED (USP); FEMALE; HYPERPLASIA; ILIAC ARTERY; MACACA FASCICULARIS; TUNICA INTIMA;

EID: 0032053716     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(98)00042-4     Document Type: Article

References (44)

1. Gruchow HW, Anderson AJ, Barboriak J, Sobocinski VA. Postmenopausal use of estrogen and occlusion of coronary arteries. Am Heart J 1988;115:954-63.
2. Sullivan JM, Vander Zwaag R, Lemp GF, et al. Postmenopausal estrogen use and coronary atherosclerosis. Ann Intern Med 1988;108:358-63.
3. Hong MK, Romm PA, Reagan K, Green CE, Rackley CE. Effects of estrogen replacement therapy on serum lipid values and angiographically defined coronary artery disease in postmenopausal women. Am J Cardiol 1992;69:176-8.
4. McFarland KF, Boniface ME, Hornung CA, Earnhardt W, Humphries JO. Risk factors and noncontraceptive estrogen use in women with and without coronary disease. Am Heart J 1989;117:1209-14.
5. Adams MR, Kaplan JR, Manuck SB, et al. Inhibition of coronary artery atherosclerosis: lack of an effect of added progesterone. Arteriosclerosis 1990;10:1051-7.
6. Kushwaha RS, Hazzard WR. Exogenous estrogens attenuate dietary hypercholesterolemia and atherosclerosis in the rabbit. Metabolism 1981;30:359-66.
7. Hough JL, Zilversmit DB. Effect of 17-beta estradiol on aortic cholesterol content and metabolism in cholesterol-fed rabbits. Arteriosclerosis 1986;6:57-63.
8. Haarbo J, Leth-Espensen P, Stender S, Christiansen C. Estrogen monotherapy and combined estrogen-progestogen replacement therapy attenuate aortic accumulation of cholesterol in ovariectomized cholesterol-fed rabbits. J Clin Invest 1991;87:1274-9.
9. Haarbo J, Svendsen OL, Christiansen C. Progestogens do not affect aortic accumulation of cholesterol in ovariectomized cholesterol-fed rabbits. Circ Res 1992;70:1198-202.
10. Rhee CY, Spaet TH, Stemmerman MB, Lajam F, Shiang HH. Estrogen suppression of surgically induced vascular intimal hyperplasia in rabbits. J Lab Clin Med 1977;90:77-84.
11. Weigensberg BI, Lough H, More RH, Katz E, Pugash E, Peniston C. Effects of estradiol on myointimal thickening from catheter injury and on organizing white mural nonocclusive thrombi. Atherosclerosis 1984;52:253-65.
12. Foegh ML, Khirabadi BS, Nakanishi T, Vargas R, Ramwell PW. Estradiol protects against experimental cardiac transplant atherosclerosis. Transplant Proc 1987;19:90-5.
13. Sullivan TR, Karas RH, Aronovitz M, et al. Estrogen inhibits the response-to-injury in a mouse carotid artery model. J Clin Invest 1995;96:2482-8.
14. Chen S-J, Li H, Durand J, Oparil S, Chen Y-F. Estrogen reduces myointimal proliferation after balloon injury of rat carotid artery. Circulation 1996;93:577-84.
15. Fischer-Dzoga K, Wissler R, Vesselinovitch D. The effect of estradiol on the proliferation of rabbit aortic medial tissue cells induced by hyperlipemic serum. Exp Mol Pathol 1983;39:355-62.
16. Vargas R, Wroblewska B, Rego A, Hatch J, Ramwell PW. Oestradiol inhibits smooth muscle cell proliferation of pig coronary artery. Br J Pharmacol 1993;109:612-7.
17. Clowes AW, Karnovsky MJ. Suppression by heparin of smooth muscle cell proliferation in injured arteries. Nature 1977;265:625-6.
18. Powell JS, Clozel JP, Muller EKM, et al. Inhibitors of angiotensin-converting enzyme prevent myointimal proliferation after vascular injury. Science 1989;245:186-8.
19. Faxon DP, Spiro TE, Minor S, for the ERA Investigators. Low molecular weight heparin in prevention of restenosis after angioplasty: results of Enoxaparin Restenosis (ERA) trial. Circulation 1994;90:908-14.
20. MERCATOR Study Group. Does the new angiotensin-converting enzyme inhibitor cilazapril prevent restenosis after percutaneous transluminal coronary angioplasty? Results of the MERCATOR study: a multicenter, randomized, double-blind placebo-controlled trial. Circulation 1992;86:100-10.
21. Faxon DP. Effect of high dose angiotensin-converting enzyme inhibition on restenosis: final results of the MERCATOR study, a multicenter, double-blind, placebo-controlled trial of cilazapril. J Am Coll Cardiol 1995;25:362-9.
22. Adams MR, Kaplan JR, Koritnik DR, Clarkson TB. Ovariectomy, social status, and atherosclerosis in cynomolgus monkeys. Arteriosclerosis 1985;5:192-200.
23. Adams MR, Register TC, Golden DL, Wagner JD, Williams JK. Medroxyprogesterone acetate antagonizes inhibitory effects of conjugated equine estrogens on coronary artery atherosclerosis. Arterioscler Thromb Vasc Biol 1997;17:217-21.
24. Geary RL, Williams JK, Golden D, Brown DG, Benjamin ME, Adams MR. Time course of cellular proliferation, intimal hyperplasia, and remodeling following angioplasty in monkeys with established atherosclerosis: a nonhuman primate model of restenosis. Arterioscler Thromb Vasc Biol 1996;16:34-43.
25. Mondy JS, Williams JK, Adams MR, Dean RH, Geary RL. Structural determinants of lumen narrowing after angioplasty in atherosclerotic nonhuman primates. J Vasc Surg 1997;26:875-83.
26. Adams MR, Clarkson TB, Koritnik DR, Nash HA. Contraceptive steroids and coronary artery atherosclerosis in cynomolgus monkeys. Fertil Steril 1987;47:1010-8.
27. Clarkson TB, Shively CA, Morgan TM, Koritnik DR, Adams MR, Kaplan JR. Oral contraceptives and coronary artery atherosclerosis of cynomolgus monkeys. Obstet Gynecol 1990;75:217-22.
28. Allain CC, Poon LS, Chan CSG, Richmond W, Fu PC. Enzymatic determination of total serum cholesterol. Clin Chem 1974;20:470-5.
29. Lipid Research Clinics Program. Manual of laboratory operations: lipid and lipoprotein analysis. Bethesda (MD): National Institutes of Health, US Department of Health, Education and Welfare, 1984. Publication No.: 75-628.
30. Fossati P, Principe L. Serum triglycerides determined colorimetrically with an enzyme that produces hydrogen peroxide. Clin Chem 1982;28:2077-80.
31. Carroll RM, Rudel LL. Lipoprotein separation and low density lipoprotein molecular weight determination using high performance gel-filtration chromatography. J Lipid Res 1983;24:200-7.
32. Auerbach BJ, Parks JS, Applebaum-Bowden D. A rapid and sensitive micro-assay for the enzymatic determination of plasma and lipoprotein cholesterol. J Lipid Res 1990;31:738-42.
33. Rudel LL, Pitts II LL, Nelson CA. Characterization of plasma low density lipoproteins of nonhuman primates fed dietary cholesterol. J Lipid Res 1977;18:211-22.
34. Sorci-Thomas M, Wilson MD, Johnson FL, Williams DL, Rudel LL. Studies on the expression of genes encoding apolipoproteins B100 and B48 and the low density lipoprotein receptor in nonhuman primates. J Biol Chem 1989;264:9039-45.
35. Koritnik DL, Rudel LL. Measurement of apolipoprotein A-I concentration in nonhuman primate serum by enzyme-linked immunosorbent assay (ELISA). J Lipid Res 1983;24:1639-45.
36. Williams JK, Honoré EK, Washburn SA, Clarkson TB. Effects of hormone replacement therapy on reactivity of atherosclerotic coronary arteries in cynomolgus monkeys. J Am Coll Cardiol 1994;24:1757-61.
37. Geary RL, Koyama N, Wang TW, Vergel S, Clowes AW. Failure of heparin to inhibit intimal hyperplasia in injured baboon arteries: the role of heparin-sensitive and heparin-insensitive pathways in the stimulation of smooth muscle cell migration and proliferation. Circulation 1995;91:2972-81.
38. De Groote P, Bauters C, McFadden EP, Leblanche J-M, Leroy F, Bertrand ME. Local lesion-related factors and restenosis after coronary angioplasty: Evidence from a quantitative angiographic study in patients with unstable angina undergoing double-vessel angioplasty. Circulation 1995;91:968-72.
39. Itoh A, Miyazaki S, Nonogi H, Daikoku S, Haze K. Angioscopic prediction of successful dilatation and of restenosis in percutaneous transluminal coronary angioplasty: significance of yellow plaque. Circulation 1995;91:1389-96.
40. Tan K, Sulke N, Taub N, Sowton E. Clinical and lesion morphologic determinants of coronary angioplasty success and complications: current experience. J Am Coll Cardiol 1995;25:855-65.
41. Jamal A, Bendeck M, Langille BL. Structural changes and recovery of function after arterial injury. Arterioscler Thromb 1992;12:307-17.
42. O'Brien ER, Alpers CE, Stewart DK, et al. Proliferation in primary and restenotic coronary atherectomy tissue: implications for antiproliferative therapy. Circ Res 1993;73:223-31.
43. Mintz GS, Popma JJ, Pichard AD, et al. Arterial remodeling after coronary angioplasty: a serial intravascular ultrasound study. Circulation 1996;94:35-43.
44. Glagov S. Intimal hyperplasia, vascular modeling, and the restenosis problem. Circulation 1994;89:2888-91.